Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Go Back to All Clinical Trials

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Brief description of study

The purpose of this research study is to see whether ticagrelor and aspirin or rivaroxaban and aspirin compared to clopidogrel and aspirin will have the most success in preventing another stroke, bleed in the brain, or death in participants who have already had a stroke from a narrowed brain artery. If you choose to participate in this study, you will be randomly assigned (like drawing straws) to one of three study treatments: ticagrelor and aspirin, rivaroxaban and aspirin, or clopidogrel and aspirin. You will receive Intensive Medical Therapy: treatment of your blood pressure, cholesterol, diabetes if you are diabetic, program to stop smoking if you smoke, and program for weight loss if you are obese. You will also have a mouthwash or cheek swab sample collected to look at the makeup of one of your genes.

Clinical Study Identifier: s22-00099

ClinicalTrials.gov Identifier: NCT05047172

Principal Investigator: Brandon Giglio.

Other Investigators: Melissa Jeannie Rethana, Laura Mary Catherine Ades, Aaron S Lord.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies